Home › Viral Infections › Maryland
Viral Infections clinical trials in Maryland
14 studies for Viral Infections are looking for participants at sites in Maryland.
Cities in Maryland
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Annapolis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT05624450Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
- National Institutes of Health Clinical Center, Bethesda
RecruitingObservational study
Ages 18 to 120 · All sexes · Updated Sep 28, 2026 · NCT00006518The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
- National Institutes of Health Clinical Center, Bethesda
RecruitingObservational study
Ages 2 to 100 · All sexes · Updated Sep 28, 2026 · NCT01011712A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Centennial Medical Group, Columbia
- Jadestone Clinical Research, Silver Spring
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 25, 2026 · NCT06679140A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Johns Hopkins Hospital, Baltimore
- Jadestone Clinical Research, Silver Spring
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07013474Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus Infection
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 50 · All sexes · Updated Sep 25, 2026 · NCT07706686Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions
- University of Maryland, Baltimore
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 24, 2026 · NCT07654283Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 50 · All sexes · Updated Sep 15, 2026 · NCT06863142Viral Infections in Healthy and Immunocompromised Hosts
- National Institutes of Health Clinical Center, Bethesda
RecruitingObservational studyHealthy volunteers welcome
6 Months – 120 Years · All sexes · Updated Sep 14, 2026 · NCT01306084Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity
- National Institutes of Health Clinical Center, Bethesda
RecruitingObservational studyHealthy volunteers welcome
2 Months – 115 Years · All sexes · Updated Sep 10, 2026 · NCT04419870Genetic Studies of Chronic Active Epstein-Barr Disease
- National Institutes of Health Clinical Center, Bethesda
RecruitingObservational study
Ages 1 to 120 · All sexes · Updated Jul 28, 2026 · NCT00032513Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)
- Johns Hopkins, Baltimore
RecruitingPhase 1/2
1 Month – 79 Years · All sexes · Updated Apr 15, 2026 · NCT04197596Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts
- Johns Hopkins University, Baltimore
- National Institutes of Health (NIH), Bethesda
RecruitingPhase 1
3 Months – 80 Years · All sexes · Updated Jan 26, 2026 · NCT04691622Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)
- All Natural Medicine Clinic, LLC, Rockville
RecruitingPhase 1/2
All ages · All sexes · Updated Feb 19, 2025 · NCT04790240From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.